Case ReportInternational Journal of Basic & Clinical Pharmacology
Publication: Acute ST-elevation myocardial infraction after use of oral sumatriptan: a rare presentation
Int J Basic Clin Pharmacol. 2020;9(11):1746-1748.DOI10.18203/2319-2003.ijbcp20204506
Abstract
Sumatriptan is an agonist of 5-hydroxytryptamine type-1 (5HT1) receptors that is widely used as a migraine abortant; however, there have been studies showing angina, coronary vasospasm, and even myocardial infraction in patients with predisposing cardiac risk factors. We present the case of a female patient with no cardiovascular risk factor who developed ST-elevation myocardial infraction 30 minutes after ingesting oral sumatriptan for her migraine.
Keywords
Affiliations
- Medical Officer, CHC, Laxmangarh, Sikar, Rajasthan, India
- Department of Cardiology, Noble Care Hospital, Sikar, Rajasthan, India
